The PRI is pleased to announce Dr. Sandrine Claus has been elected Association President (effective 9 January 2023). As President, Sandrine will lead the Executive Committee and Board of Directors within the Association. Since the last update to the PRI Bylaws (Dec 2020), the President as well as the Executive Committee have taken on a more involved role in guiding the Association’s strategic path as well as working closely with the PRI staff, led by Executive Director Magali Cordaillat-Simmons.
A clear regulatory framework is an accelerator for product development. It shows the path to transforming an amazing scientific discovery into a product that will benefit society. The microbiome field is blooming with innovations that have the potential to revolutionize human and animal healthcare. Yet, the lack of clear regulatory guidelines can be intimidating for many to venture on the path towards regulatory approval. The PRI brings together microbiome experts, product developers, and service providers to carve this necessary regulatory path and support Members on this journey. In doing so, the PRI actively contributes to developing the microbiome sector. Therefore, I feel privileged to support the PRI on this mission and to succeed Bruno Pot as the new President. Bruno has brilliantly led the PRI for the last 8 years. The strong and efficient working relationship he forged with Magali Cordaillat-Simmons, Executive Director, has been decisive in shaping the Association and making it successful. I am thus delighted that he will remain a part of the Executive Committee as 1st Vice-President. I am also extremely pleased that this newly elected Executive Committee is complemented by these equally-talented individuals: Michelle Carr, Stanislas Desjonquères, and Françoise Le Vacon. Together, we are committed to collectively building on our experience to support Magali and her team. I am confident that this synergy will guide our actions to further develop the Association, successfully tackle future challenges, and ultimately continue to thrive in serving the PRI Members.
Sandrine Claus, YSOPIA Bioscience & Microbiome CS
Newly-elected Executive Committee to continue the PRI Vision & Strategy (2021-2025) Roadmap
Following last month’s General Assembly (1 Dec. 2022 in Rotterdam, NL) when the PRI Membership elected the new Board of Directors for the 2022-2024 Term, one of the Board’s first steps was electing its 5-Member Executive Committee. Joining Sandrine at the head of Europe’s Microbiome Regulatory Science Center are former President (now 1st Vice-President) Bruno Pot, Science Director for Yakult Europe, 2nd Vice-President Michelle Carr, Growth Senior Project Manager for Ferring Pharmaceuticals, Secretary Françoise Le Vacon, CSO for Biofortis, and Treasurer Stanislas Desjonquères, CEO for Nexbiome Therapeutics, and Founder of the PRI.
The Executive Committee is at the heart of the Association’s work as they set the operational agenda and summon Board of Directors meetings. They play a primary role in the pursuit of the Association’s objectives and strategic decisions in close collaboration with the PRI Executive Director and her Staff.
Working in transformational fields such as the microbiome is both exciting and a privilege. The PRI team has worked diligently to build awareness and knowledge of the microbiome and its regulatory science which is essential in enabling potentially life-changing products for patients to be realised. I am honoured to have been elected to the PRI Executive Committee and along with my peers, I look forward to leveraging my strategic and commercial experience to support Magali and the PRI team in this industry-critical mission.
Michelle Carr, Ferring Pharmaceuticals
Françoise Le Vacon, Biofortis SAS
Special thanks to Stanislas Desjonquères and Bruno Pot for their continued committment to the organization
Stanislas is the PRI’s Founder and has served since its creation in 2010 as the Association Treasurer. His vision and committment to this organization is unwavering – the PRI Staff continue to count on his strategic guidance, as well as his love of numbers!
Stanislas Desjonquères, Nexbiome Therapeutics
Bruno Pot, Yakult Europe